Tirzepatide 100mg
Toro Labs Tirzepatide 100mg is the ultimate high capacity research vial, designed for prolonged study protocols with maximum efficiency. Dual action and precision dosed with purity verified on every batch.
Key Details
- 100mg per vial
- Lyophilised (freeze dried) powder
- Requires reconstitution with bacteriostatic water
- Batch tested via HPLC analysis
- Toro Labs authenticated product
Research Benefits
- Dual GIP and GLP-1 receptor agonist for enhanced metabolic regulation
- Extensively studied for superior weight management outcomes
- Supports improved glycaemic control and insulin sensitivity
- May outperform single receptor agonists in fat reduction studies
- Promotes sustained appetite suppression with less frequent dosing
- Highest yield vial for cost effective long term research
Suggested Research Protocol
- Starting dose: 2.5mg per week, titrating up gradually
- Maintenance dose: 5mg to 15mg per week
- Administered via subcutaneous injection
- Standard research cycle: 12 to 20 weeks or beyond
- Store reconstituted vial refrigerated at 2 to 8°C
Quality Assurance Every vial is batch coded and lab verified. Full HPLC purity reports available on request. Manufactured under strict ISO conditions by Toro Laboratories.
